Description

Advanced Retatrutide 30mg 

At GLP1 Peptides, we specialize in providing the scientific community with high-yield research compounds. Retatrutide 30mg represents the pinnacle of modern peptide synthesis, functioning as a unimolecular triple agonist that targets three distinct metabolic pathways.

The 30mg concentration is ideal for researchers requiring higher dosages for comprehensive studies. Retatrutide is uniquely engineered to target:

1. GLP-1 (Glucagon-Like Peptide-1)

2. GIP (Glucose-Dependent Insulinotropic Polypeptide)

3. GR (Glucagon Receptor)

This triple-action mechanism makes it an indispensable tool for investigating multi-receptor signaling and advanced energy homeostasis.

The GLP1 Peptides Quality Standard

• 99% Purity Guaranteed: Every batch of Retatrutide 30mg is verified through HPLC and Mass Spectrometry to ensure a purity rating of 99% or higher.

• Professional Lyophilization: Our advanced freeze-drying process protects the delicate molecular structure of the peptide, ensuring long-term stability and shelf life in a laboratory setting.

• Analytical Transparency: Every shipment is accompanied by a batch-specific Certificate of Analysis (COA), providing the data integrity required for high-level scientific experimentation.

• Sequence Accuracy: Our synthesis protocols prioritize precise amino acid sequencing to ensure a reliable and consistent research analog.

Technical Product Specifications:

• Compound Name: Retatrutide

• Vial Concentration: 30mg Single Compound

• Format: White Lyophilized Powder

• Target Receptors: GIP, GLP-1, and Glucagon

• Purity Rating: >99%

• Storage: Recommended storage at -20°C to maintain stability and potency.